These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26399136)

  • 21. Orkambi in patients with severe disease - Bumps in the road to CFTR modulation.
    Horsley A; Barry P
    J Cyst Fibros; 2017 May; 16(3):311-312. PubMed ID: 28433526
    [No Abstract]   [Full Text] [Related]  

  • 22. Game Changers.
    Ulster Med J; 2015 Oct; 84(3):218-9. PubMed ID: 26668427
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmaceuticals issue brief: pharmaceutical assistance programs: year end report--2004.
    Seay M
    Issue Brief Health Policy Track Serv; 2004 Dec; ():1-26. PubMed ID: 15724309
    [No Abstract]   [Full Text] [Related]  

  • 24. Making medicines affordable: the price factor (position paper).
    American Public Health Association
    Am J Public Health; 2001 Mar; 91(3):486-90. PubMed ID: 11236429
    [No Abstract]   [Full Text] [Related]  

  • 25. Controversies with Kalydeco: Newspaper coverage in Canada and the United States of the cystic fibrosis "wonder drug".
    Rachul C; Toews M; Caulfield T
    J Cyst Fibros; 2016 Sep; 15(5):624-9. PubMed ID: 27150823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prescription drug prices in Canada.
    Gross D
    Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2003 Jun; (IB62):1-22. PubMed ID: 12807123
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug prices. In search of a fix.
    Bell H
    Minn Med; 2001 Jan; 84(1):24-8, 30-1. PubMed ID: 11202523
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmaceuticals and medical devices: Medicare Part D. Issue brief.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Dec; ():1-32. PubMed ID: 23297447
    [No Abstract]   [Full Text] [Related]  

  • 29. Is There a Cure for High Drug Prices? A Special Investigation From Consumer Reports Best Buy Drugs.
    Consum Rep; 2016 Aug; 81(8):52-60. PubMed ID: 27459753
    [No Abstract]   [Full Text] [Related]  

  • 30. Prescription drug costs easier to swallow.
    State Legis; 2010 Apr; 36(4):10. PubMed ID: 20397320
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharma APMs: Can the Industry Learn To Play Well With Others?
    Alston M; Pyenson B
    Manag Care; 2018 Sep; 27(9):31-32. PubMed ID: 30216160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flexible prescription assistance program for patients with cystic fibrosis.
    Hilmas E; Black J; Gagliano R; Henderson D; Long S; Rosenstein B; Wohl ME
    Am J Health Syst Pharm; 2004 Aug; 61(15):1590-3. PubMed ID: 15372833
    [No Abstract]   [Full Text] [Related]  

  • 33. Doubts emerge about drug industry mergers.
    Bus Health; 1994 Nov; 12(11):53-4, 56, 61. PubMed ID: 10138536
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug firms and insurers move to center stage in the cost debate.
    Goozner M
    Mod Healthc; 2015 Feb; 45(8):26. PubMed ID: 25823208
    [No Abstract]   [Full Text] [Related]  

  • 35. Australia-United States Free Trade Agreement and the Australian Pharmaceutical Benefits Scheme.
    Sainsbury P
    Yale J Health Policy Law Ethics; 2004; 4(2):387-99. PubMed ID: 15536920
    [No Abstract]   [Full Text] [Related]  

  • 36. Prescription-drug coupons--no such thing as a free lunch.
    Ross JS; Kesselheim AS
    N Engl J Med; 2013 Sep; 369(13):1188-9. PubMed ID: 23984672
    [No Abstract]   [Full Text] [Related]  

  • 37. Value Tools Not in The Insurer Toolkit-Yet.
    Silverman E
    Manag Care; 2016 Oct; 25(10):16-17. PubMed ID: 28121538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacy Plus: the perfect cure?
    Cauchi R
    State Legis; 2003 Feb; 29(2):20-1. PubMed ID: 12577977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The new Medicare prescription-drug legislation.
    Altman DE
    N Engl J Med; 2004 Jan; 350(1):9-10. PubMed ID: 14702422
    [No Abstract]   [Full Text] [Related]  

  • 40. "Insuring" the continued solvency of pharmaceutical companies in the face of product liability class actions.
    Chodock R; Yolkut D; Connolly DR
    Tort Trial Insur Pract Law J; 2005; 40(3):997-1017. PubMed ID: 16100814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.